VS:01 Welcome Remarks and Metabolic Dysfunction Associated Steatotic Liver Disease: What You Need to Know
8:00 AM - 9:10 AM
Speaker: Peter Buch, MD
Just when we got comfortable with NonAlcoholic Fatty Liver Disease, the terminology changed! Why? And how do we assess and treat Metabolic Dysfunction Associated Steatotic Liver Disease and Metabolic Dysfunction Associated Steatohepatitis? Please join Peter Buch, MD, for a practical, case-based, very interactive and fun presentation where you will acquire a virtual clinical toolchest which will greatly assist you in the management of these patients.
Break
9:10 AM - 9:20 AM
VS:02 An Integrative Approach to Gastroenterology
9:20 AM - 10:20 AM
Speaker: Brianna Bonne, PA
This session introduces a functional medicine perspective to gastrointestinal care, emphasizing a holistic, root-cause approach to common GI symptoms. Attendees will learn how to use targeted diagnostic tools to uncover dysfunction in the GI tract and apply personalized treatment strategies that incorporate dietary shifts, lifestyle modifications and thoughtful supplementation. By focusing on the underlying causes rather than isolated symptoms, this approach supports more effective and sustainable outcomes for patients.
Break
10:20 AM - 10:30 AM
VS:03 Sedation
10:30 AM - 11:30 AM
Speakers: Derrick Duarte, CRNA APRN and Karrina Mock, CRNA APRN
Managing sedation in the gastroenterology setting requires a clear understanding of sedation levels, patient assessment and individualized care. This presentation will explore key differences between moderate sedation, deep sedation and monitored anesthesia care, along with techniques for airway evaluation and anticipating difficult bag-mask ventilation. It will also cover monitoring requirements, commonly used sedatives and how to tailor sedation strategies for patients with respiratory, cardiac or renal conditions.
Lunch
11:30 AM - 12:15 PM
VS:04 Colon Cancer
12:15 PM - 1:15 PM
Speaker: Whitney Jones, MD
This session explains the changing epidemiology of CRC and how to introduce CRC risk evaluations as a benchmark in the endoscopy unit. It also discusses the role of Lead Time Messaging to deliver more on-time, elevated, and average-risk CRC screening. Lastly, it reviews state, community, and endoscopy unit-level ideas to accelerate the impact of new technology and drive quality improvement.
Break
1:15 PM - 1:25 PM
VS:05 Celiac Disease
1:25 PM - 2:25 PM
Speaker: Eric Meyer, PA-C
Understanding celiac disease is essential for accurate diagnosis and effective patient care. This presentation will define the condition, outline how it differs from non-celiac gluten sensitivity and walk through the steps required for proper diagnosis. Attendees will also gain insight into evidence-based treatment strategies to support long-term management and improve patient outcomes.
Break
2:25 PM - 2:35 PM
VS:06 GLP-1
2:35 PM - 3:35 PM
Speaker: Amy Doran, MD
With the rising popularity of GLP-1 agonists for weight loss, gastroenterology professionals are increasingly encountering patients using these medications. This session will review the origins and development of GLP-1 agonists, explore their pharmacodynamics, and examine common gastrointestinal side effects. Discussion will also include important procedural considerations for patients taking GLP-1 agonists, equipping attendees with practical insights for safer, more informed care.
Breakfast With the Board
8:00 AM - 8:30 PM
Speakers: SGNA Board of Directors
VS:07 Pelvic Floor Dysfunction
8:50 AM - 9:50 AM
Speaker: Shelby Wills, DNP APRN CNP
Pelvic floor dysfunction is a complex and often chronic condition requiring a nuanced, multidisciplinary approach. Led by a nurse practitioner and a physical therapist specializing in pelvic floor therapy, this session will explore the fundamental components of the disorder, examine contributing risk factors and outline key diagnostic considerations. Attendees will compare treatment strategies and gain insight into how to deliver safe, effective care for patients managing this often-overlooked condition.
Break
9:50 AM – 10:00 AM
VS:08 ATP Testing
10:00 AM – 11:00 AM
Speaker: Marshall E McCabe III, MD
This session explains how ATP testing works and its limitations. It reviews methods for assessing calibration and accuracy of ATP measurements, examples of how ATP testing can be used as a process improvement tool, why different ATP measuring systems have different Pass/Fail RLUs and different ATP testing and borescope examination guidelines.
Lunch
11:00 AM – 11:45 AM
VS:09 Chronic Pancreatitis: “It Is All About the Pain”
11:45 AM – 12:45 PM
Speaker: James Watkins, MD
This session discusses how endoscopic and surgical therapy of pancreatic stones is driven by pain, and guidelines suggest that there is no role for these therapies in patients with no symptoms. It explains the limitations of “standard endoscopic techniques” as used for biliary stones, which are often not effective for pancreatic stone disease. It also will describe how Extracorporeal Shock Wave Lithotripsy (ESWL ) for therapy of pancreatic duct stones and the evolution of endoscopic evaluation and therapy of pancreatic duct stones. Lastly, it reviews surgical options in treatment of pancreatic stone disease.
Break
12:45 PM - 12:55 PM
VS:10 Liver Disease
12:55 PM - 1:55 PM
Speaker: Teri A. Derimanoczy, MSN FNP-BC RN CGRN
Our closing session will describe the function and anatomy of the liver, the etiology of MASLD and MASH, risk factors associated with MASLD and will review the newest research on liver disease and treatment options.